230 related articles for article (PubMed ID: 7949203)
1. Aromatase inhibitors--mechanisms of steroidal inhibitors.
Brueggemeier RW
Breast Cancer Res Treat; 1994; 30(1):31-42. PubMed ID: 7949203
[TBL] [Abstract][Full Text] [Related]
2. Exploring new chemical functionalities to improve aromatase inhibition of steroids.
Varela CL; Amaral C; Correia-da-Silva G; Costa SC; Carvalho RA; Costa G; Alcaro S; Teixeira NA; Tavares-da-Silva EJ; Roleira FM
Bioorg Med Chem; 2016 Jun; 24(12):2823-31. PubMed ID: 27160054
[TBL] [Abstract][Full Text] [Related]
3. Aromatase, aromatase inhibitors, and breast cancer.
Brueggemeier RW
Am J Ther; 2001; 8(5):333-44. PubMed ID: 11550075
[TBL] [Abstract][Full Text] [Related]
4. Biochemistry and pharmacology of 7alpha-substituted androstenediones as aromatase inhibitors.
Brueggemeier RW; O'Reilly JM; Lovely CJ; Ward PJ; Quinn AL; Baker D; Darby MV; Gu XJ; Gilbert NE
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):247-54. PubMed ID: 9365197
[TBL] [Abstract][Full Text] [Related]
5. [Development of aromatase inhibitors and analysis of their inhibitory activities].
Numazawa M
Yakugaku Zasshi; 1998 Dec; 118(12):539-53. PubMed ID: 9921263
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of new steroidal inhibitors of estrogen synthase (aromatase).
Parish EJ; Li S; Rao Z
Lipids; 2000 Mar; 35(3):271-7. PubMed ID: 10783004
[TBL] [Abstract][Full Text] [Related]
7. Aromatase, its inhibitors and their use in breast cancer treatment.
Brodie AM
Pharmacol Ther; 1993 Dec; 60(3):501-15. PubMed ID: 8073072
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer.
Lønning PE
Breast Cancer Res Treat; 1998; 49 Suppl 1():S45-52; discussion S73-7. PubMed ID: 9797017
[TBL] [Abstract][Full Text] [Related]
9. Biological characterization of A-ring steroids.
Johnston JO; Wright CL; Burkhart JP; Peet NP
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):623-31. PubMed ID: 8476773
[TBL] [Abstract][Full Text] [Related]
10. Aromatase inhibition by 7-substituted steroids in human choriocarcinoma cell culture.
Brueggemeier RW; Katlic NE; Kenreigh CA; Li PK
J Steroid Biochem Mol Biol; 1992 Jan; 41(1):85-90. PubMed ID: 1734938
[TBL] [Abstract][Full Text] [Related]
11. Aromatase inhibitors: new endocrine treatment of breast cancer.
Brueggemeier RW
Semin Reprod Med; 2004 Feb; 22(1):31-43. PubMed ID: 15083379
[TBL] [Abstract][Full Text] [Related]
12. Probing the binding pocket of the active site of aromatase with 6-ether or 6-ester substituted androst-4-ene-3,17-diones and their diene and triene analogs.
Numazawa M; Shelangouski M; Nagasaka M
Steroids; 2000 Dec; 65(12):871-82. PubMed ID: 11077085
[TBL] [Abstract][Full Text] [Related]
13. An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors.
Neves MA; Dinis TC; Colombo G; Sá e Melo ML
Eur J Med Chem; 2009 Oct; 44(10):4121-7. PubMed ID: 19500885
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of aromatase inhibition by new A, D-ring modified steroids.
Cepa M; Correia-da-Silva G; Tavares da Silva EJ; Roleira FM; Hong Y; Chen S; Teixeira NA
Biol Chem; 2008 Sep; 389(9):1183-91. PubMed ID: 18713005
[TBL] [Abstract][Full Text] [Related]
15. Exemestane, a new steroidal aromatase inhibitor of clinical relevance.
Lombardi P
Biochim Biophys Acta; 2002 Jul; 1587(2-3):326-37. PubMed ID: 12084475
[TBL] [Abstract][Full Text] [Related]
16. Aromatase and its inhibitors in breast cancer treatment--overview and perspective.
Brodie AM; Santen RJ
Breast Cancer Res Treat; 1994; 30(1):1-6. PubMed ID: 7949200
[TBL] [Abstract][Full Text] [Related]
17. Probing the active site of aromatase with 2-methyl-substituted androstenedione analogs.
Numazawa M; Watari Y; Yamada K; Umemura N; Handa W
Steroids; 2003 Aug; 68(6):503-13. PubMed ID: 12906935
[TBL] [Abstract][Full Text] [Related]
18. [Progress in study of the structure, catalytic mechanism and inhibitors of aromatase].
Fu J; Shen ZH; Cheng FX; Liu GX; Li WH; Tang Y
Yao Xue Xue Bao; 2012 Jan; 47(1):18-28. PubMed ID: 22493800
[TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibitors in the treatment of breast cancer.
Brueggemeier RW; Hackett JC; Diaz-Cruz ES
Endocr Rev; 2005 May; 26(3):331-45. PubMed ID: 15814851
[TBL] [Abstract][Full Text] [Related]
20. Binding features of steroidal and nonsteroidal inhibitors.
Hong Y; Rashid R; Chen S
Steroids; 2011 Jul; 76(8):802-6. PubMed ID: 21420422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]